JAAOS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Acad Orthop Surg, Vol 16, No 2, February 2008, 98-106.
© 2008 the American Academy of Orthopaedic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marcotte, A. L.
Right arrow Articles by Trzeciak, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marcotte, A. L.
Right arrow Articles by Trzeciak, M. A.

Community-acquired Methicillin-resistant Staphylococcus aureus: An Emerging Pathogen in Orthopaedics

Anthony L. Marcotte, DO and Marc A. Trzeciak, DO

Dr. Marcotte is Resident, Department of Orthopedic Surgery, Grandview Hospital and Medical Center, Dayton, OH. Dr. Trzeciak is Professor, Department of Hand and Upper Extremity Surgery, Ohio University, Dayton, and Orthopaedic Attending, The Hand Center of Southwestern Ohio, A Division of Orthopedic Associates of Southwestern Ohio, Dayton.

None of the following authors or a member of their immediate families has received anything of value from or owns stock in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Marcotte and Dr. Trzeciak.

Reprint requests: Dr. Trzeciak, The Hand Center of Southwestern Ohio, A Division of Orthopedic Associates of Southwestern Ohio, Suite 10, 4160 Little York Road, Dayton OH 45415.

Staphylococcus aureus (S aureus) remains one of the most common pathogens for skin and soft-tissue infections encountered by the orthopaedic surgeon. Community-acquired methicillin-resistant S aureus (CA-MRSA) has become increasingly prevalent, particularly among athletes, children in day care, homeless persons, intravenous drug users, men who have sex with men, military recruits, certain minorities (ie, Alaskan Natives, Native Americans, Pacific Islanders), and prison inmates. Risk factors include antibiotic use within the preceding year, crowded living conditions, compromised skin integrity, contaminated surfaces, frequent skin-to-skin contact, shared items, and suboptimal cleanliness. When a patient presents with a skin or soft-tissue infection, the clinician should determine whether an abscess or other infection needs to be surgically incised and drained. Cultures should be performed. When the patient is a member of an at-risk group or has any of the risk factors for CA-MRSA, β-lactam antibiotics (eg, methicillin) are no longer a reasonable choice for treatment. Empiric treatment should consist of non–β-lactam antibiotics active against CA-MRSA.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Academy of Orthopaedic Surgeons.